München
02.06.26 | 08:02
0,084 Euro
-4,02 % -0,004
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,070 | 0,088 | 02.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Ventripoint Diagnostics Ltd.: Ventripoint Announces Adoption of Semi-Annual Reporting (SAR) | 2 | TheNewswire | ||
| 25.05. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 25.05. | Ventripoint Diagnostics Ltd.: Ventripoint Provides Videoconference Link to Annual General Meeting and Corporate Update | 4 | TheNewswire | ||
| 22.05. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics closes $308,030 financing | 1 | Stockwatch | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 22.05. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of $308,030 Non-Brokered Units Private Placement | 1 | TheNewswire | ||
| 20.05. | Ventripoint Diagnostics Ltd (2): Ventripoint issues shares for interest of $61,217 | 1 | Stockwatch | ||
| 19.05. | Ventripoint Diagnostics Ltd.: Ventripoint Issues Shares for Payment of Debenture Interest | 1 | TheNewswire | ||
| 15.05. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 555,699 shares for debt | 1 | Stockwatch | ||
| 04.05. | Ventripoint Diagnostics Ltd.: Ventripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology | 1 | TheNewswire | ||
| 29.04. | Ventripoint Diagnostics Ltd (2): Ventripoint's VMS+ 4.0 submitted for approval in China | 1 | Stockwatch | ||
| 28.04. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 28.04. | Ventripoint Diagnostics Ltd.: Ventripoint's VMS+ 4.0 Submitted for Regulatory Approval in China by Lishman Global Inc. | 2 | TheNewswire | ||
| 23.04. | Ventripoint Diagnostics Ltd (2): Ventripoint to issue 555,699 shares as interest payment | 1 | Stockwatch | ||
| 22.04. | Ventripoint Diagnostics Ltd.: Ventripoint Issue Shares for Payment of Debenture Interest | 2 | TheNewswire | ||
| 20.04. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 20.04. | Ventripoint Diagnostics Ltd.: Ventripoint's VMS+ 4.0 Recognized with Gold Edison Award, Validating Leadership and Future Potential | 1 | TheNewswire | ||
| 02.04. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 01.04. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group | 1 | TheNewswire | ||
| 17.03. | Ventripoint Diagnostics Ltd (2): Ventripoint, FLH expand AI cardiac care to remote areas | 1 | Stockwatch | ||
| 17.03. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,012 | -11,43 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 4,240 | +0,95 % | Atossa presents preclinical data on breast cancer drug at ASCO | ||
| UNIDOC HEALTH | 0,062 | 0,00 % | UniDoc Health Corp.: UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase | AMD Telemedicine software and related systems now fully integrated; UniDoc Connect used at more than 800 sites across 48 countries VANCOUVER, BC / ACCESS Newswire / May 21, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,038 | -16,48 % | Mountain Valley MD Holdings Inc: Mountain Valley MD appoints advisers, grants options | ||
| TANDEM DIABETES | 15,700 | -1,88 % | TNDM Stock: What to Know About Tandem's 2026 Reset | ||
| MOLINA HEALTHCARE | 153,80 | -0,58 % | MOLINA HEALTHCARE, INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
| VERU | 2,360 | +0,43 % | Veru Inc.: Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | --Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for interim analysis first quarter calendar year 2027- --Company to host conference call and... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,280 | +1,86 % | Jim Cramer on Clover Health: "You're in Pure Spec Mode There" | ||
| LIGHT AI | 0,151 | -4,75 % | Photonics Theme Gains Momentum In ETF Market As GraniteShares Files 'Speed Of Light AI ETF' | ||
| IMAGIN MEDICAL | 0,001 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2026.ISIN NameCA2985962067 EUREKA... ► Artikel lesen | |
| FRESENIUS | 36,450 | +2,82 % | dpa-AFX-Überblick: UNTERNEHMEN vom 26.05.2026 - 15.15 Uhr | Schwerwiegende Bedenken: BP trennt sich von Verwaltungsratschef - Kursrutsch LONDON - Der britische Ölkonzern BP setzt seinen Verwaltungsratschef Albert Manifold wegen Vorwürfen vor die Tür. Als... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 35,690 | -1,95 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von rund EUR 1 Milliarde in Tranchen | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Kapitalmaßnahmen / Aktienrückkäufe
Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,34 | 0,00 % | Morgan Stanley raises BrightSpring Health price target on valuation | ||
| ALIGNMENT HEALTHCARE | 13,640 | 0,00 % | Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report | ||
| SIEMENS HEALTHINEERS | 34,040 | -0,64 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU)... ► Artikel lesen |
Das Unternehmen VENTRIPOINT DIAGNOSTICS LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -4,02 % bei einem Aktienkurs von 0,084 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.